{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:19:54Z","timestamp":1788531594195,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J011201"],"award-info":[{"award-number":["2025J011201"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02322-6","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:36:03Z","timestamp":1785836163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of doxycycline treatment with time to first documented MP-RNA negative conversion in pediatric Mycoplasma pneumoniae pneumonia: a retrospective cohort study"],"prefix":"10.1186","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2482-5014","authenticated-orcid":false,"given":"Di","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2322_CR1","doi-asserted-by":"publisher","first-page":"1625206","DOI":"10.3389\/fped.2025.1625206","volume":"13","author":"D Lian","year":"2025","unstructured":"Lian D, Lin C, Dong X, Wei J, Huang X, Jiang H, et al. Development and validation of a CD4+\/CD8\u2009+\u2009ratio-based nomogram to predict plastic bronchitis in pediatric Mycoplasma pneumoniae pneumonia. Front Pediatr. 2025;13:1625206. https:\/\/doi.org\/10.3389\/fped.2025.1625206.","journal-title":"Front Pediatr"},{"key":"2322_CR2","doi-asserted-by":"publisher","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949.","DOI":"10.1001\/jamanetworkopen.2022.20949"},{"key":"2322_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS Wang","year":"2024","unstructured":"Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024;20:901\u201314. https:\/\/doi.org\/10.1007\/s12519-024-00831-0.","journal-title":"World J Pediatr"},{"key":"2322_CR4","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","volume":"26","author":"YC Chen","year":"2020","unstructured":"Chen YC, Hsu WY, Chang TH. Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia. Emerg Infect Dis. 2020;26:1382\u201391. https:\/\/doi.org\/10.3201\/eid2607.200017.","journal-title":"Emerg Infect Dis"},{"key":"2322_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","volume":"21","author":"JG Ahn","year":"2021","unstructured":"Ahn JG, Cho HK, Li D, Choi M, Lee J, Eun BW, et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:1003. https:\/\/doi.org\/10.1186\/s12879-021-06508-7.","journal-title":"BMC Infect Dis"},{"key":"2322_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/antibiotics10020192","volume":"10","author":"H Lee","year":"2021","unstructured":"Lee H, Choi YY, Sohn YJ, Kim YK, Han MS, Yun KW, et al. Clinical efficacy of doxycycline for treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Antibiotics. 2021;10:192. https:\/\/doi.org\/10.3390\/antibiotics10020192.","journal-title":"Antibiotics"},{"key":"2322_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","volume":"8","author":"F Zhao","year":"2019","unstructured":"Zhao F, Li J, Liu J, Guan X, Gong J, Liu L, et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019;8:143. https:\/\/doi.org\/10.1186\/s13756-019-0576-5.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2322_CR8","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2018","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.","edition":"31"},{"key":"2322_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NPJ, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood: time to rebuild its reputation? Expert Opin Drug Saf. 2016;15:367\u201382. https:\/\/doi.org\/10.1517\/14740338.2016.1133584.","journal-title":"Expert Opin Drug Saf"},{"key":"2322_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2180-8-93","volume":"8","author":"AC Nilsson","year":"2008","unstructured":"Nilsson AC, Bj\u00f6rkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93. https:\/\/doi.org\/10.1186\/1471-2180-8-93.","journal-title":"BMC Microbiol"},{"key":"2322_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fped.2019.00441","volume":"7","author":"J Li","year":"2019","unstructured":"Li J, Sun L, Wu X, Guo Y, Jiao W, Xiao J, et al. Early diagnosis of Mycoplasma pneumoniae in children: simultaneous amplification and testing (SAT) is the key. Front Pediatr. 2019;7:441. https:\/\/doi.org\/10.3389\/fped.2019.00441.","journal-title":"Front Pediatr"},{"key":"2322_CR12","doi-asserted-by":"publisher","unstructured":"Li W, Fang YH, Shen HQ, Yang DH, Shu Q, Shang SQ. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia. PLoS ONE. 2017;12(5). https:\/\/doi.org\/10.1371\/journal.pone.0177842.","DOI":"10.1371\/journal.pone.0177842"},{"key":"2322_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"2322_CR14","first-page":"79","volume":"50","author":"National Health Commission of the People\u2019s Republic of China","year":"2023","unstructured":"National Health Commission of the People\u2019s Republic of China. Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children: 2023 edition. Int J Epidemiol Infect Dis. 2023;50:79\u201385.","journal-title":"Int J Epidemiol Infect Dis"},{"key":"2322_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12887-024-05380-z","volume":"25","author":"D Lian","year":"2025","unstructured":"Lian D, Lin C, Zhang Z, Wei J, Wang D, Tang Q. Clinical diagnostic value of throat swabs in pediatric acute lower respiratory tract infections using targeted next-generation sequencing. BMC Pediatr. 2025;25:224. https:\/\/doi.org\/10.1186\/s12887-024-05380-z.","journal-title":"BMC Pediatr"},{"key":"2322_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","volume":"20","author":"C Yan","year":"2024","unstructured":"Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J. Current status of Mycoplasma pneumoniae infection in China. World J Pediatr. 2024;20:1\u20134. https:\/\/doi.org\/10.1007\/s12519-023-00783-x.","journal-title":"World J Pediatr"},{"key":"2322_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, Goret J, B\u00e9b\u00e9ar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. https:\/\/doi.org\/10.3389\/fmicb.2016.00974.","journal-title":"Front Microbiol"},{"key":"2322_CR18","doi-asserted-by":"publisher","first-page":"300060521101637","DOI":"10.1177\/03000605211016376","volume":"49","author":"C Xu","year":"2021","unstructured":"Xu C, Deng H, Zhang J, Zhu Y, Rong Q, Quan Y, et al. Mutations in domain V of Mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China. J Int Med Res. 2021;49:3000605211016376. https:\/\/doi.org\/10.1177\/03000605211016376.","journal-title":"J Int Med Res"},{"key":"2322_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-021-01061-7","volume":"61","author":"EN Drwiega","year":"2022","unstructured":"Drwiega EN, Rodvold KA. Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update. Clin Pharmacokinet. 2022;61:17\u201346. https:\/\/doi.org\/10.1007\/s40262-021-01061-7.","journal-title":"Clin Pharmacokinet"},{"key":"2322_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-024-01615-y","volume":"50","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang Y, Tang QN, Shi HB. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods. Ital J Pediatr. 2024;50:38. https:\/\/doi.org\/10.1186\/s13052-024-01615-y.","journal-title":"Ital J Pediatr"},{"key":"2322_CR21","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21037\/tp-21-356","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen J, Qi X, Yin Y, Zhang L, Zhang J, Yuan S. Effects of minocycline on macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a single-center retrospective study. Transl Pediatr. 2021;10:2997\u20133004. https:\/\/doi.org\/10.21037\/tp-21-356.","journal-title":"Transl Pediatr"},{"key":"2322_CR22","doi-asserted-by":"publisher","first-page":"1727627","DOI":"10.3389\/fpubh.2026.1727627","volume":"14","author":"S Liu","year":"2026","unstructured":"Liu S, Zhang L, Dai L, Li D. Timing and efficacy of doxycycline in macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a single-center retrospective study. Front Public Health. 2026;14:1727627. https:\/\/doi.org\/10.3389\/fpubh.2026.1727627.","journal-title":"Front Public Health"},{"key":"2322_CR23","doi-asserted-by":"publisher","first-page":"6990995","DOI":"10.1155\/ijcp\/6990995","volume":"2026","author":"L Zheng","year":"2026","unstructured":"Zheng L, Yu S, Liao C, Xiao G, Dai Q, Ye Q. Effectiveness of early doxycycline intervention in treating macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Int J Clin Pract. 2026;2026:6990995. https:\/\/doi.org\/10.1155\/ijcp\/6990995.","journal-title":"Int J Clin Pract"},{"key":"2322_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-025-05393-1","volume":"45","author":"K Zheng","year":"2026","unstructured":"Zheng K, Zhou SH, Han ZB. Clinical efficacy comparison of doxycycline versus azithromycin combined with methylprednisolone in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children. Eur J Clin Microbiol Infect Dis. 2026;45:1059\u201367. https:\/\/doi.org\/10.1007\/s10096-025-05393-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2322_CR25","doi-asserted-by":"publisher","unstructured":"Fu R, Liu X, Liu F, Huang X, Zhao D, Chen Q. DNA and RNA detection of inactivated Mycoplasma pneumoniae in different microenvironments. Pediatr Pulmonol. 2025;60(3). https:\/\/doi.org\/10.1002\/ppul.71040.","DOI":"10.1002\/ppul.71040"},{"key":"2322_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-026-05428-1","author":"B Jiang","year":"2026","unstructured":"Jiang B, Zhao H, Yan C, Wang M, Wang Z, Feng Y, et al. Comparison between DNA- and RNA-based nucleic acid amplification tests for detecting Mycoplasma pneumoniae in pediatric specimens. Eur J Clin Microbiol Infect Dis. 2026. https:\/\/doi.org\/10.1007\/s10096-026-05428-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2322_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13052-025-02156-8","volume":"51","author":"R Yang","year":"2025","unstructured":"Yang R, Xu H, Zhang Z, Zhao R, Liu Q, Liu M, et al. Doxycycline vs levofloxacin for macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a real-world study from China. Ital J Pediatr. 2025;51:320. https:\/\/doi.org\/10.1186\/s13052-025-02156-8.","journal-title":"Ital J Pediatr"},{"key":"2322_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10238-025-01793-x","volume":"25","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Sang X, Gao D, Zhang Z, Xuan A, Peng W. Efficacy and safety of doxycycline for severe Mycoplasma pneumoniae pneumonia in pediatric patients. Clin Exp Med. 2025;25:259. https:\/\/doi.org\/10.1007\/s10238-025-01793-x.","journal-title":"Clin Exp Med"},{"key":"2322_CR29","doi-asserted-by":"publisher","first-page":"1644231","DOI":"10.3389\/fped.2025.1644231","volume":"13","author":"K Ma","year":"2025","unstructured":"Ma K, Lu M, Li H, Yuan X, Zhang Y, Ni Q, et al. Incidence and influencing factors of tooth discoloration in children using doxycycline: a meta-analysis. Front Pediatr. 2025;13:1644231. https:\/\/doi.org\/10.3389\/fped.2025.1644231.","journal-title":"Front Pediatr"},{"key":"2322_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"XW Zhan","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, Zhang J, Wang MZ, Li SJ. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2022;48:190. https:\/\/doi.org\/10.1186\/s13052-022-01376-6.","journal-title":"Ital J Pediatr"},{"key":"2322_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21101\/cejph.a8434","volume":"33","author":"L Ba\u010da","year":"2025","unstructured":"Ba\u010da L, Slov\u00e1kov\u00e1 L, Vo\u010dkov\u00e1 J, Dole\u017ealov\u00e1 K. Rising incidence of Mycoplasma pneumoniae pneumonias in a tertiary paediatric centre: implications for antibiotic therapy. Cent Eur J Public Health. 2025;33:77\u20139. https:\/\/doi.org\/10.21101\/cejph.a8434.","journal-title":"Cent Eur J Public Health"},{"key":"2322_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/IDR.S502937","volume":"18","author":"Q Sun","year":"2025","unstructured":"Sun Q, Hao J, Zhou Q, Zeng Y. Clinical characteristics and treatment outcomes of pediatric drug-resistant Mycoplasma pneumoniae pneumonia in the post-COVID-19 era. Infect Drug Resist. 2025;18:957\u201363. https:\/\/doi.org\/10.2147\/IDR.S502937.","journal-title":"Infect Drug Resist"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02322-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:37:05Z","timestamp":1788529025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2322"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02322-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Fujian Children\u2019s Hospital (protocol code 2026ETKLRK03001, approval date March 13, 2026). The requirement for informed consent for this retrospective data analysis was waived; however, written informed consent for the off-label clinical use of doxycycline had been routinely obtained from the guardians of all children under 8 years of age prior to treatment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"135"}}